论文部分内容阅读
系统性红斑狼疮(SLE)是一种累及多器官多系统的自身免疫性疾病,产生多种自身抗体是其特点,抗心磷脂抗体(ACA)是其中一种,已被列入1997年SLE诊断标准中[1]。目前认为β2糖蛋白Ⅰ(β2GPⅠ)是ACA的主要靶抗原。本研究探讨了SLE患者抗β2GPⅠ与ACA及SLE疾病活动指数(SLEDAI)[1]的相
Systemic lupus erythematosus (SLE) is a multi-organ involving multiple systems of autoimmune diseases, to produce a variety of autoantibodies are its characteristics, anti-cardiolipin antibodies (ACA) is one of them, has been included in the 1997 SLE diagnosis Standard [1]. It is currently believed that β2 glycoprotein Ⅰ (β2GP Ⅰ) is the main target antigen of ACA. This study explored the anti-β2GPⅠ and SLE patients with ACA and SLE disease activity index (SLEDAI) [1] of the phase